The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
FIVE9 INC COM 338307101   487,878 6,200 SH   SOLE   6,200 0 0
HH&L ACQUISITION CO *W EXP 02/04/202 G39714129   10,000 400,000 SH   SOLE   400,000 0 0
MONGODB INC CL A 60937P106   490,620 1,200 SH   SOLE   1,200 0 0
NVIDIA CORPORATION COM 67066G104   990,440 2,000 SH   SOLE   2,000 0 0
YS BIOPHARMA CO LTD *W EXP 03/15/202 G9845F117   28,500 750,000 SH   SOLE   750,000 0 0
YS BIOPHARMA CO LTD ORDINARY SHARES G9845F109   821,266 1,607,175 SH   SOLE   1,607,175 0 0